These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17498511)

  • 1. Obesity and atherogenic dyslipidemia.
    Bamba V; Rader DJ
    Gastroenterology; 2007 May; 132(6):2181-90. PubMed ID: 17498511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)].
    Farnier M
    Arch Mal Coeur Vaiss; 2007 Dec; 100(12):979-84. PubMed ID: 18223510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M; Ginsberg HN; Schaefer EJ
    Am J Cardiol; 2008 Apr; 101(7):1003-8. PubMed ID: 18359322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
    Palaniappan LP; Kwan AC; Abbasi F; Lamendola C; McLaughlin TL; Reaven GM
    Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure.
    Onat A; Ayhan E; Hergenç G; Can G; Barlan MM
    Metabolism; 2009 Jul; 58(7):963-70. PubMed ID: 19411085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atherogenic dyslipidaemia in type 2 diabetes].
    Zozulińska D
    Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S567-71. PubMed ID: 20527378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity-related changes in high-density lipoprotein metabolism.
    Mooradian AD; Haas MJ; Wehmeier KR; Wong NC
    Obesity (Silver Spring); 2008 Jun; 16(6):1152-60. PubMed ID: 18388903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.
    Bays HE; Toth PP; Kris-Etherton PM; Abate N; Aronne LJ; Brown WV; Gonzalez-Campoy JM; Jones SR; Kumar R; La Forge R; Samuel VT
    J Clin Lipidol; 2013; 7(4):304-83. PubMed ID: 23890517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents.
    Posadas-Sánchez R; Posadas-Romero C; Zamora-González J; Mendoza-Pérez E; Cardoso-Saldaña G; Yamamoto-Kimura L
    Metabolism; 2007 Dec; 56(12):1666-72. PubMed ID: 17998019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCSK9 and resistin at the crossroads of the atherogenic dyslipidemia.
    Rashid S; Kastelein JJ
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1567-77. PubMed ID: 24134510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
    Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
    Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid and insulin levels in obese children: changes with age and puberty.
    Pinhas-Hamiel O; Lerner-Geva L; Copperman NM; Jacobson MS
    Obesity (Silver Spring); 2007 Nov; 15(11):2825-31. PubMed ID: 18070774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and types of dyslipidemia in PCOS.
    Diamanti-Kandarakis E; Papavassiliou AG; Kandarakis SA; Chrousos GP
    Trends Endocrinol Metab; 2007 Sep; 18(7):280-5. PubMed ID: 17692530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel peroxisome proliferator--activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys.
    Ding SY; Tigno XT; Braileanu GT; Ito K; Hansen BC
    Metabolism; 2007 Oct; 56(10):1334-9. PubMed ID: 17884441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.